Early in the COVID-19 pandemic, individuals with Alzheimer's disease were identified as being at increased risk of developing severe COVID-19.

C2N Diagnostics is experiencing a couple of breakthroughs with its Alzheimers disease detection test - one courtesy of FDA. The agency, which is slowly rising back to full strength after the temporary government shutdown, granted the St. Lou

Brigham and Womens Hospital investigators are working on a test that could either diagnose or predict Alzheimers disease before symptoms appear. The investigators approach is in the December issue of Alzheimers Dementia. Tau proteins have lo